VYGR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.53%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $62,186.51

Voyager Therapeutics Insider Trading History Chart

Voyager Therapeutics Share Price & Price History

^$5.75

▲ +0.06 (1.05%)

As of 12/20/2024 06:17 PM ET

Days: 30 | 90 | 365

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Voyager Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/2/2024	Sandell Jacquelyn Fahey	Insider	Sell	5,999	$5.82	$34,914.18	86,001
1/17/2024	Robin Swartz	COO	Sell	2,543	$7.15	$18,182.45	72,327
1/17/2024	Todd Alfred Carter	Insider	Sell	1,266	$7.18	$9,089.88	53,094
10/3/2023	Peter P Pfreundschuh	CFO	Sell	13,567	$6.99	$94,833.33	149,433
9/15/2023	Todd Alfred Carter	Insider	Sell	10,500	$8.16	$85,680.00	54,360
7/6/2023	Todd Alfred Carter	Insider	Sell	5,500	$10.80	$59,400.00	59,860
4/3/2023	Alfred Sandrock	CEO	Sell	7,437	$7.83	$58,231.71	214,618
4/3/2023	Robin Swartz	COO	Sell	1,259	$7.83	$9,857.97	71,617
3/20/2023	Robert W Hesslein	VP	Sell	4,410	$7.76	$34,221.60	102,200
3/20/2023	Robin Swartz	COO	Sell	3,654	$7.76	$28,355.04	72,876
3/20/2023	Todd Alfred Carter	Insider	Sell	2,193	$7.76	$17,017.68	65,360
2/23/2023	Neurocrine Biosciences Inc	Major Shareholder	Buy	4,395,588	$8.88	$39,032,821.44	8,575,316
2/17/2023	Robert W Hesslein	VP	Sell	3,297	$7.45	$24,562.65	106,610
2/17/2023	Todd Alfred Carter	Insider	Sell	738	$7.45	$5,498.10	67,553
2/13/2023	Robert W Hesslein	VP	Sell	2,868	$7.67	$21,997.56	109,907
2/13/2023	Todd Alfred Carter	Insider	Sell	797	$7.67	$6,112.99	34,291
2/1/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	128,642	$9.32	$1,198,943.44	4,685,291
1/30/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	75,000	$9.03	$677,250.00	4,998,933
1/27/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	50,000	$9.02	$451,000.00	5,073,933
1/25/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	50,000	$9.22	$461,000.00	5,123,933
1/23/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	55,000	$9.06	$498,300.00	5,273,933
1/20/2023	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	100,000	$9.15	$915,000.00	5,328,933
1/17/2023	Robert W Hesslein	VP	Sell	2,188	$9.85	$21,551.80	112,775
1/17/2023	Todd Alfred Carter	Insider	Sell	1,106	$9.85	$10,894.10	35,088
1/11/2023	Ecor1 Capital, Llc	Major Shareholder	Sell	110,000	$8.50	$935,000.00	3,851,507
1/9/2023	Ecor1 Capital, Llc	Major Shareholder	Sell	456,000	$7.67	$3,497,520.00	4,297,907
8/24/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	149,972	$6.09	$913,329.48	5,628,933
8/15/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	135,808	$6.04	$820,280.32	5,907,361
8/12/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	348,007	$6.12	$2,129,802.84	6,043,169
7/14/2022	Glenn Pierce	Director	Sell	9,512	$6.70	$63,730.40	16,788
6/23/2022	Ecor1 Capital, Llc	Major Shareholder	Buy	376,000	$5.66	$2,128,160.00	4,753,907
6/21/2022	Ecor1 Capital, Llc	Major Shareholder	Buy	101,400	$5.28	$535,392.00	4,377,907
4/4/2022	Robert W Hesslein	VP	Sell	2,786	$8.25	$22,984.50	114,963
4/4/2022	Robin Swartz	COO	Sell	1,527	$8.25	$12,597.75	52,060
3/21/2022	Robert W Hesslein	VP	Sell	4,955	$8.29	$41,076.95
3/21/2022	Robin Swartz	COO	Sell	4,413	$8.29	$36,583.77
2/11/2022	Robert W Hesslein	VP	Sell	3,252	$3.36	$10,926.72
1/12/2022	Julie Burek	VP	Sell	265	$3.06	$810.90
1/3/2022	Julie Burek	VP	Sell	3,063	$2.83	$8,668.29

First JFK… next Elon?

From Porter & Company | Ad

I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for Voyager Therapeutics (NASDAQ:VYGR)

48.03% of Voyager Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Voyager Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	104,462	$0.61M	0.0%	+55.8%	0.191%
11/16/2024	Geode Capital Management LLC	1,079,509	$6.32M	0.0%	+0.6%	1.976%
11/15/2024	Barclays PLC	104,462	$0.61M	0.0%	+55.8%	0.192%
11/15/2024	Jane Street Group LLC	84,652	$0.50M	0.0%	-56.1%	0.155%
11/15/2024	Wellington Management Group LLP	229,369	$1.34M	0.0%	-7.1%	0.421%
11/15/2024	State Street Corp	892,743	$5.22M	0.0%	-50.1%	1.637%
11/15/2024	Erste Asset Management GmbH	1,058,378	$6.19M	0.1%	N/A	1.941%
11/14/2024	PDT Partners LLC	22,163	$0.13M	0.0%	-70.7%	0.041%
11/14/2024	Verition Fund Management LLC	37,006	$0.22M	0.0%	N/A	0.068%
11/14/2024	Vestal Point Capital LP	490,000	$2.87M	0.2%	-18.3%	0.899%
11/13/2024	Great Point Partners LLC	959,953	$5.62M	1.7%	-40.1%	1.760%
11/13/2024	BNP Paribas Financial Markets	49,235	$0.29M	0.0%	+30.5%	0.090%
11/13/2024	FMR LLC	92,498	$0.54M	0.0%	+26.9%	0.170%
11/12/2024	Charles Schwab Investment Management Inc.	137,477	$0.80M	0.0%	+2.6%	0.252%
11/12/2024	Massachusetts Financial Services Co. MA	171,856	$1.01M	0.0%	+19.7%	0.315%
11/9/2024	Intech Investment Management LLC	12,714	$74K	0.0%	N/A	0.023%
11/6/2024	Empowered Funds LLC	44,809	$0.26M	0.0%	+5.4%	0.082%
11/6/2024	Cornercap Investment Counsel Inc.	10,937	$64K	0.0%	-52.4%	0.020%
10/25/2024	China Universal Asset Management Co. Ltd.	10,489	$61K	0.0%	+64.1%	0.019%
10/24/2024	Patriot Financial Group Insurance Agency LLC	136,894	$0.80M	0.1%	+7.0%	0.252%
10/19/2024	Allspring Global Investments Holdings LLC	31,740	$0.19M	0.0%	-66.5%	0.058%
10/16/2024	Hunter Perkins Capital Management LLC	64,040	$0.38M	0.1%	+3.3%	0.117%
8/15/2024	The Manufacturers Life Insurance Company	94,398	$0.75M	0.0%	+6.0%	0.173%
8/15/2024	AQR Capital Management LLC	502,375	$3.97M	0.0%	-36.7%	0.921%
8/15/2024	Armistice Capital LLC	5,200,000	$41.13M	0.5%	+11.3%	9.536%
8/14/2024	Great Point Partners LLC	1,601,527	$12.67M	2.4%	N/A	2.937%
8/14/2024	Profund Advisors LLC	16,762	$0.13M	0.0%	-11.4%	0.031%
8/12/2024	Hsbc Holdings PLC	16,240	$0.13M	0.0%	N/A	0.030%
8/9/2024	Renaissance Technologies LLC	63,200	$0.50M	0.0%	-50.7%	0.116%
8/9/2024	Dimensional Fund Advisors LP	813,680	$6.44M	0.0%	-26.4%	1.496%
8/9/2024	Massachusetts Financial Services Co. MA	143,523	$1.14M	0.0%	+3.5%	0.264%
8/9/2024	WINTON GROUP Ltd	36,027	$0.29M	0.0%	-51.6%	0.066%
8/8/2024	Federated Hermes Inc.	554,214	$4.38M	0.0%	+0.5%	1.019%
8/8/2024	American Century Companies Inc.	1,019,332	$8.06M	0.0%	+32.4%	1.874%
8/7/2024	ClariVest Asset Management LLC	102,822	$0.81M	0.1%	+2.7%	0.189%
8/6/2024	Acadian Asset Management LLC	106,825	$0.84M	0.0%	-76.8%	0.196%
8/5/2024	Victory Capital Management Inc.	12,892	$0.10M	0.0%	+14.5%	0.024%
8/1/2024	Rhumbline Advisers	72,461	$0.57M	0.0%	+56.0%	0.133%
8/1/2024	Ritholtz Wealth Management	11,556	$91K	0.0%	-24.9%	0.021%
7/31/2024	Commonwealth Equity Services LLC	77,905	$0.62M	0.0%	+36.8%	0.143%
7/26/2024	Patriot Financial Group Insurance Agency LLC	127,894	$1.01M	0.1%	N/A	0.235%
7/26/2024	Allspring Global Investments Holdings LLC	94,774	$0.75M	0.0%	-4.6%	0.174%
7/26/2024	Bank of New York Mellon Corp	294,420	$2.33M	0.0%	+17.7%	0.541%
7/24/2024	SummerHaven Investment Management LLC	77,293	$0.61M	0.4%	+2.5%	0.142%
7/17/2024	Hunter Perkins Capital Management LLC	62,015	$0.49M	0.1%	-4.8%	0.114%
7/12/2024	SG Americas Securities LLC	10,780	$85K	0.0%	N/A	0.020%
5/24/2024	Farallon Capital Management LLC	2,292,000	$21.34M	0.1%	+77.4%	4.214%
5/17/2024	Ikarian Capital LLC	180,857	$1.68M	0.2%	-40.9%	0.333%
5/17/2024	Plato Investment Management Ltd	4,119	$38K	0.0%	N/A	0.008%
5/16/2024	California State Teachers Retirement System	3,957	$37K	0.0%	-24.3%	0.007%
5/16/2024	Virtus Investment Advisers Inc.	12,648	$0.12M	0.1%	N/A	0.023%
5/15/2024	Price T Rowe Associates Inc. MD	1,041,930	$9.70M	0.0%	+3.7%	1.916%
5/15/2024	Lazard Asset Management LLC	18,742	$0.17M	0.0%	+95.3%	0.034%
5/14/2024	EntryPoint Capital LLC	10,039	$93K	0.1%	-51.6%	0.018%
5/14/2024	American International Group Inc.	19,397	$0.18M	0.0%	+22.9%	0.036%
5/13/2024	O Shaughnessy Asset Management LLC	21,849	$0.20M	0.0%	-21.6%	0.040%
5/13/2024	Ameritas Investment Partners Inc.	3,923	$37K	0.0%	+49.6%	0.007%
5/10/2024	Acadian Asset Management LLC	459,850	$4.28M	0.0%	+10.1%	0.845%
5/10/2024	Vanguard Group Inc.	3,231,698	$30.09M	0.0%	+27.8%	5.942%
5/8/2024	ProShare Advisors LLC	10,876	$0.10M	0.0%	N/A	0.020%
5/7/2024	ClariVest Asset Management LLC	100,123	$0.93M	0.1%	+59.3%	0.184%
5/7/2024	Empowered Funds LLC	39,471	$0.37M	0.0%	+8.2%	0.073%
5/1/2024	BNP Paribas Financial Markets	48,769	$0.45M	0.0%	+198.6%	0.090%
4/30/2024	Commonwealth Equity Services LLC	56,955	$0.53M	0.0%	N/A	0.105%
4/29/2024	China Universal Asset Management Co. Ltd.	10,404	$97K	0.0%	+104.3%	0.019%
4/24/2024	Assenagon Asset Management S.A.	28,896	$0.27M	0.0%	+60.9%	0.053%
4/23/2024	Hunter Perkins Capital Management LLC	65,165	$0.61M	0.1%	N/A	0.120%
4/18/2024	Allspring Global Investments Holdings LLC	99,306	$0.93M	0.0%	+2.1%	0.183%
2/14/2024	ADAR1 Capital Management LLC	185,894	$1.57M	0.6%	N/A	0.423%
2/13/2024	Tower Research Capital LLC TRC	6,399	$54K	0.0%	+302.5%	0.015%
2/13/2024	Armistice Capital LLC	4,236,000	$35.75M	0.5%	+1.4%	9.629%
2/8/2024	Massachusetts Financial Services Co. MA	110,926	$0.94M	0.0%	-3.1%	0.252%
2/6/2024	AJOVista LLC	4,573	$39K	0.0%	N/A	0.010%
2/5/2024	SummerHaven Investment Management LLC	74,146	$0.63M	0.4%	+1.9%	0.169%
1/31/2024	Federated Hermes Inc.	551,576	$4.66M	0.0%	-5.5%	1.254%
1/30/2024	Cornercap Investment Counsel Inc.	23,217	$0.20M	0.0%	N/A	0.053%
1/25/2024	Allspring Global Investments Holdings LLC	97,276	$0.82M	0.0%	+27.4%	0.221%
1/24/2024	China Universal Asset Management Co. Ltd.	5,093	$43K	0.0%	N/A	0.012%
1/18/2024	Ritholtz Wealth Management	19,759	$0.17M	0.0%	+11.8%	0.045%
1/17/2024	Assenagon Asset Management S.A.	17,960	$0.15M	0.0%	-47.4%	0.041%
1/16/2024	Raymond James Financial Services Advisors Inc.	28,802	$0.24M	0.0%	-5.8%	0.065%
12/18/2023	Gladius Capital Management LP	3,182	$25K	0.0%	N/A	0.007%
12/18/2023	Vanguard Group Inc.	2,481,957	$19.24M	0.0%	+0.2%	5.642%
11/15/2023	Alps Advisors Inc.	37,900	$0.29M	0.0%	N/A	0.086%
11/15/2023	Armistice Capital LLC	4,178,000	$32.38M	0.5%	+15.3%	9.498%
11/14/2023	O Shaughnessy Asset Management LLC	51,690	$0.40M	0.0%	+131.2%	0.118%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	36,425	$0.28M	0.0%	-67.2%	0.083%
11/13/2023	Federated Hermes Inc.	583,885	$4.53M	0.0%	-0.7%	1.327%
11/13/2023	Acadian Asset Management LLC	630,163	$4.88M	0.0%	-12.4%	1.432%
11/13/2023	Silverarc Capital Management LLC	103,966	$0.81M	0.2%	+4.0%	0.236%
11/13/2023	Aigen Investment Management LP	14,063	$0.11M	0.0%	N/A	0.032%
11/13/2023	WINTON GROUP Ltd	49,626	$0.39M	0.0%	+103.9%	0.113%
11/13/2023	Kestra Advisory Services LLC	126,483	$0.98M	0.0%	N/A	0.287%
11/9/2023	Deutsche Bank AG	64,832	$0.50M	0.0%	-4.6%	0.148%
11/8/2023	Massachusetts Financial Services Co. MA	114,431	$0.89M	0.0%	N/A	0.261%
11/8/2023	Hussman Strategic Advisors Inc.	52,500	$0.41M	0.1%	N/A	0.120%
11/7/2023	Barclays PLC	18,309	$0.14M	0.0%	+188.8%	0.042%
11/7/2023	Ascension Capital Advisors Inc.	14,500	$0.11M	0.1%	N/A	0.033%
11/6/2023	Assenagon Asset Management S.A.	34,159	$0.27M	0.0%	-82.9%	0.078%
10/27/2023	Allspring Global Investments Holdings LLC	76,360	$0.59M	0.0%	N/A	0.174%

Data available starting January 2016

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $5.75

$5.53

$5.87

50 Day Range

MA: $6.49

$5.27

$8.07

52 Week Range

Now: $5.75

$5.19

$11.72

Volume

570,635 shs

Average Volume

628,970 shs

Market Capitalization

$314.10 million

P/E Ratio

8.10

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Voyager Therapeutics?: Voyager Therapeutics' top insider investors include:
Neurocrine Biosciences Inc (Major Shareholder)
Rock Ventures Iii LP Third (Major Shareholder)
Ecor1 Capital, Llc (Major Shareholder)
Alfred Sandrock (CEO)
Peter P Pfreundschuh (CFO)
Robert W Hesslein (VP)
Sandell Jacquelyn Fahey (Insider)
Robin Swartz (COO)
Todd Alfred Carter (Insider)
Learn More about top insider investors at Voyager Therapeutics.
Who are the major institutional investors of Voyager Therapeutics?: Voyager Therapeutics' top institutional shareholders include:
Geode Capital Management LLC — 1.98%
Erste Asset Management GmbH — 1.94%
Great Point Partners LLC — 1.76%
State Street Corp — 1.64%
Vestal Point Capital LP — 0.90%
Wellington Management Group LLP — 0.42%
Learn More about top institutional investors of Voyager Therapeutics stock.
Which major investors are selling Voyager Therapeutics stock?: During the previous quarter, VYGR stock was sold by these institutional investors:
State Street Corp
Great Point Partners LLC
Vestal Point Capital LP
Jane Street Group LLC
Allspring Global Investments Holdings LLC
PDT Partners LLC
Wellington Management Group LLP
Cornercap Investment Counsel Inc.
Within the last year, company insiders that have sold Voyager Therapeutics company stock include:
Neurocrine Biosciences Inc (Major Shareholder)
Rock Ventures Iii LP Third (Major Shareholder)
Ecor1 Capital, Llc (Major Shareholder)
Learn More investors selling Voyager Therapeutics stock.
Which major investors are buying Voyager Therapeutics stock?: In the last quarter, VYGR stock was bought by institutional investors including:
Erste Asset Management GmbH
Barclays PLC
Barclays PLC
Verition Fund Management LLC
Massachusetts Financial Services Co. MA
FMR LLC
Intech Investment Management LLC
BNP Paribas Financial Markets